查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1646736

全球虫媒病毒检测市场

Arbovirus Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 173 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球虫媒病毒检测市场规模将达到 18 亿美元

2024 年全球虫媒病毒检测市场规模估计为 13 亿美元，预计到 2030 年将达到 18 亿美元，2024-2030 年分析期间的复合年增长率为 5.9%。 ELISA 测试是报告中分析的细分市场之一，预计在分析期结束时复合年增长率为 5.5%，达到 10 亿美元。在分析期内，基于 RT-PCR 的测试部分预计将以 6.3% 的复合年增长率成长。

美国市场规模估计为 3.303 亿美元，中国市场预期复合年增长率为 9.0%

预计2024年美国虫媒病毒检测市值将达3.303亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 4.19 亿美元，在 2024 年至 2030 年的分析期内，复合年增长率为 9.0%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 3.5% 和 4.5%。在欧洲，德国的复合年增长率预计为 4.0%。

全球虫媒病毒检测市场-主要趋势与驱动因素摘要

为什么虫媒病毒检测对现代公共卫生很重要？

虫媒病毒（节肢动物传播的病毒）透过被感染的节肢动物（例如蚊子和蜱虫）叮咬传播给人类，对全世界的公共卫生构成了重大挑战。随着兹卡病毒、登革热、基孔肯雅病和西尼罗河病毒等疾病成为流行病，尤其是在热带和亚热带地区，对有效的虫媒病毒检测的需求从未如此强烈。早期准确检测这些病毒对于控制疫情、指导治疗和实施预防措施至关重要。虫媒病毒检测包括多种诊断方法，包括PCR（聚合酵素链锁反应）等分子生物学技术、检测抗体的血清学检测以及细胞培养中的病毒分离。这些检测的重要性在于它们能够确认感染、区分不同的虫媒病毒并为流行病学监测提供重要资料。由于气候变迁、都市化和全球旅行增加等因素导致全球虫媒病毒感染发病率增加，检测对于减少这些疾病影响的作用在公共卫生工作中变得越来越重要。

科技进步如何增强虫媒病毒检测？

技术进步大大提高了虫媒病毒检测的能力和准确性，从而可以更快、更可靠地进行诊断并更好地管理疫情。分子诊断技术，特别是即时PCR，彻底改变了虫媒病毒检测方式，可以快速、高度特异性地检测病毒 RNA（通常在数小时内完成）。这些技术使得区分密切相关的病毒成为可能，并且在多种虫媒病毒流行的地区至关重要。此外，次世代定序仪(NGS) 已成为虫媒病毒识别和表征的有力工具，提供了对病毒遗传学的详细了解，并有助于检测新的和正在出现的菌株。携带式和就地检验设备的创新也扩大了在偏远和资源有限的环境中获得虫媒病毒诊断的机会，因为及时诊断对这些环境至关重要。这些进步，加上人工智慧和机器学习在资料分析中的整合，不仅提高了虫媒病毒检测的准确性和效率，也使得公共卫生应对更加积极主动。

哪些新兴趋势将影响虫媒病毒检测的未来？

几个新兴趋势正在塑造虫媒病毒检测的未来，反映了公共卫生策略、技术创新和环境因素的更广泛变化。一个重要的趋势是人们越来越重视可以从单一样本同时检测多种病原体的多重测试。这将简化诊断过程并为公共卫生决策提供更全面的资料，这在不同虫媒病毒共同传播的地区尤其重要。另一个重要趋势是开发血清学检测，提高其敏感性和特异性，可以更准确地检测过去的感染并衡量人群的免疫水平。此外，数位健康平台和行动应用程式在疾病监测中的广泛使用增强了虫媒病毒病例的追踪和报告，有利于即时监测疫情。此外，诊断资料与环境资料（如天气和蚊子数量趋势）的整合正变得越来越普遍，从而可以对虫媒病毒的传播进行预测建模。这些趋势正在刺激虫媒病毒检测领域的创新，并确保其仍然是全球卫生安全的关键组成部分。

哪些因素推动了虫媒病毒检测市场的成长？

虫媒病毒检测市场的成长受到技术进步、公共卫生需求不断发展和环境变化等多种因素的推动。首先，全球虫媒病毒感染发生率不断上升，特别是在受气候变迁和都市化影响的地区，推动了对可靠且扩充性的检测解决方案的需求。其次，分子诊断和就地检验技术的进步扩大了虫媒病毒检测的可近性和效率，使得在临床和现场环境中能够更快、更准确地进行诊断。第三，特别是在旅游和旅游业领域，人们对预防性卫生措施的认识和实施不断提高，对预防性检测和监测系统的需求也在增加。此外，以媒介传播感染疾病控制为重点的全球卫生计画不断扩大，正在刺激对虫媒病毒检测基础设施和监测的投资增加。这些因素，加上创新诊断工具的发展和数位健康技术的日益融合，正在刺激虫媒病毒检测市场的强劲成长，使其成为全球对抗新兴感染疾病的关键要素。

部分

检测类型（基于 ELISA 的检测、基于 RT-PCR 的检测）；最终使用者（公共卫生实验室、医院、诊断中心、其他最终使用者）

受访公司范例（总合42家公司）

  • Alere, Inc.
  • Diamedix Corporation
  • Euroimmun AG
  • Focus Diagnostics, Inc.
  • IBL International GmbH
  • NovaTec Immundiagnostica GmbH
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP10361

Global Arbovirus Testing Market to Reach US$1.8 Billion by 2030

The global market for Arbovirus Testing estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.8 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. ELISA-based Tests, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$1.0 Billion by the end of the analysis period. Growth in the RT-PCR based Tests segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$330.3 Million While China is Forecast to Grow at 9.0% CAGR

The Arbovirus Testing market in the U.S. is estimated at US$330.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$419.0 Million by the year 2030 trailing a CAGR of 9.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Arbovirus Testing Market - Key Trends and Drivers Summarized

Why Is Arbovirus Testing Crucial in Modern Public Health?

Arboviruses, or arthropod-borne viruses, are transmitted to humans through the bites of infected mosquitoes, ticks, and other arthropods, posing significant public health challenges worldwide. With diseases such as Zika, Dengue, Chikungunya, and West Nile Virus becoming more prevalent, especially in tropical and subtropical regions, the need for effective arbovirus testing has never been more critical. Early and accurate detection of these viruses is essential for controlling outbreaks, guiding treatment, and implementing preventive measures. Arbovirus testing encompasses a range of diagnostic methods, including molecular techniques like PCR (Polymerase Chain Reaction), serological tests to detect antibodies, and virus isolation in cell cultures. The importance of these tests lies in their ability to confirm infections, differentiate between various arboviruses, and provide critical data for epidemiological surveillance. As the global incidence of arbovirus infections rises, driven by factors such as climate change, urbanization, and increased global travel, the role of testing in mitigating the impact of these diseases is becoming increasingly central to public health efforts.

How Are Technological Advances Enhancing Arbovirus Testing?

Technological advances are significantly enhancing the capabilities and accuracy of arbovirus testing, enabling faster, more reliable diagnosis, and better outbreak management. Molecular diagnostics, particularly real-time PCR, have revolutionized arbovirus testing by offering rapid and highly specific detection of viral RNA, often within hours. These techniques allow for the differentiation of closely related viruses, which is crucial in regions where multiple arboviruses are endemic. Additionally, next-generation sequencing (NGS) is emerging as a powerful tool in the identification and characterization of arboviruses, providing detailed insights into viral genetics and aiding in the detection of novel or emerging strains. Innovations in portable and point-of-care testing devices are also expanding access to arbovirus diagnostics in remote or resource-limited settings, where timely diagnosis is critical. These advancements, coupled with the integration of AI and machine learning in data analysis, are not only improving the accuracy and efficiency of arbovirus testing but also enabling more proactive public health responses.

What Emerging Trends Are Shaping the Future of Arbovirus Testing?

Several emerging trends are shaping the future of arbovirus testing, reflecting broader changes in public health strategies, technological innovation, and environmental factors. One significant trend is the increasing emphasis on multiplex testing, which allows for the simultaneous detection of multiple pathogens from a single sample. This is particularly important in regions where co-circulation of different arboviruses is common, as it streamlines the diagnostic process and provides more comprehensive data for public health decision-making. Another important trend is the development of serological tests with improved sensitivity and specificity, which can more accurately detect past infections and measure population immunity levels. Additionally, the growing use of digital health platforms and mobile apps for disease surveillance is enhancing the tracking and reporting of arbovirus cases, facilitating real-time monitoring of outbreaks. The integration of environmental data, such as climate and mosquito population trends, with diagnostic data is also becoming more prevalent, enabling more predictive modeling of arbovirus spread. These trends are driving innovation in the field of arbovirus testing, ensuring that it remains a critical component of global health security.

What Factors Are Driving Growth in the Arbovirus Testing Market?

The growth in the arbovirus testing market is driven by several factors that align with technological advancements, evolving public health needs, and environmental changes. Firstly, the increasing global incidence of arbovirus infections, particularly in regions affected by climate change and urbanization, is propelling demand for reliable and scalable testing solutions. Secondly, advancements in molecular diagnostics and point-of-care testing technologies are expanding the accessibility and efficiency of arbovirus testing, enabling quicker and more accurate diagnosis in both clinical and field settings. Thirdly, the growing awareness and implementation of preventive health measures, particularly in travel and tourism, are driving demand for preemptive testing and surveillance systems. Additionally, the expansion of global health initiatives focused on combating vector-borne diseases is fostering increased investment in arbovirus testing infrastructure and research. These factors, combined with the ongoing development of innovative diagnostic tools and the integration of digital health technologies, are fueling robust growth in the arbovirus testing market, positioning it as a critical element in the global fight against emerging infectious diseases.

SCOPE OF STUDY:

The report analyzes the Arbovirus Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (ELISA-Based Tests, RT-PCR Based Tests); End-Use (Public Health Laboratory, Hospitals, Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Alere, Inc.
  • Diamedix Corporation
  • Euroimmun AG
  • Focus Diagnostics, Inc.
  • IBL International GmbH
  • NovaTec Immundiagnostica GmbH
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Arbovirus Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Arbovirus Infections Spurs Growth in Testing Demand
    • Advancements in Molecular Diagnostics Propel Innovation in Arbovirus Testing
    • Increasing Adoption of Multiplex Testing Strengthens Business Case for Advanced Diagnostics
    • Expansion of Point-of-Care Testing Solutions Drives Accessibility in Remote Areas
    • Growing Use of AI and Machine Learning in Data Analysis Enhances Testing Accuracy
    • Increasing Focus on Travel-Related Health Measures Expands Market Opportunities
    • Advancements in Serological Testing Drive Demand for Enhanced Immunity Monitoring
    • Here's How Portable Testing Devices Are Enhancing Response Capabilities in Epidemic Zones
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for ELISA-based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for ELISA-based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for ELISA-based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for RT-PCR based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for RT-PCR based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for RT-PCR based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Public Health Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Arbovirus Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Arbovirus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Arbovirus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Arbovirus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Arbovirus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Arbovirus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Arbovirus Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Arbovirus Testing by End-Use - Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Public Health Laboratory, Hospitals, Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION